SCHEMBL2317331

SCHEMBL2317331

CCCCC=CC1=CC2CCC1C2

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15922796 0.95 L3MBTL1 (0.35) L3MBTL1
SCHEMBL15923385 0.94 ALDH1A1 (0.35) L3MBTL1
SCHEMBL15922776 0.94 ALDH1A1 (0.35) L3MBTL1
SCHEMBL15922997 0.94 ALDH1A1 (0.35) L3MBTL1
SCHEMBL1450946 0.83
SCHEMBL10544135 0.75 CNR1 (0.33)
SCHEMBL4290581 0.73
SCHEMBL4428973 0.73
SCHEMBL9500161 0.66 KDM4E (0.34)
SCHEMBL649223 0.65 SPHK1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119059869-A Preparation method of tetrahydrodicyclopentadiene 中国石油化工股份有限公司 2024-12-03 CN disclosed
CN-119060757-A Method for removing olefin from reformate 中国石油化工股份有限公司 2024-12-03 CN disclosed
WO-2024118568-A1 METHODS OF MAKING COMPOSITIONS FROM OLEFIN METATHESIS PHOTOPOLYMERS PolySpectra, Inc. (US) 2024-06-06 WO disclosed
WO-2024074909-A1 ARTICLES COMPRISING CYCLIC OLEFIN, CATALYST, AND SECOND POLYMERIZABLE MATERIAL, METHODS AND COMPOSITIONS 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-04-11 WO disclosed
WO-2023023188-A1 METHODS OF MAKING COMPOSITIONS FROM OLEFIN METATHESIS PHOTOPOLYMERS PolySpectra, Inc. (US) 2023-02-23 WO disclosed
CN-107406646-B Resin composition and use thereof 三井化学株式会社 2020-06-09 CN disclosed
EP-2898551-B1 ORGANIC SEMICONDUCTOR FORMULATIONS MERCK PATENT GMBH (DE) 2020-04-22 EP disclosed
EP-3507007-A1 PHOTOACTIVE CATALYST COMPOSITIONS California Institute of Technology (US) 2019-07-10 EP disclosed
EP-3500557-A1 OLEFIN METATHESIS CATALYSTS UMICORE AG & CO. KG (DE) 2019-06-26 EP disclosed
EP-3411217-A1 THREE-DIMENSIONAL INKJET PRINTING USING RING-OPENING METATHESIS POLYMERIZATION Stratasys Ltd. (IL) 2018-12-12 EP disclosed
WO-2014121008-A1 NORBORNENYLHYDROCARBYLENE DIHYDROCARBYLBORANES AND METHODS OF MAKING THE SAME PROMERUS, LLC (US) 2014-08-07 WO disclosed
EP-2756112-A2 IMPROVED ELECTROLYTIC CELL COVERS COMPRISING A RESIN COMPOSITION POLYMERIZED WITH A GROUP 8 OLEFIN METATHESIS CATALYST Materia, Inc. (US) 2014-07-23 EP disclosed
WO-2014055720-A1 PHOTOINITIATED OLEFIN METATHESIS POLYMERIZATION CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-04-10 WO disclosed
WO-2014044359-A1 ORGANIC SEMICONDUCTOR FORMULATIONS MERCK PATENT GMBH (DE) 2014-03-27 WO disclosed
WO-2014022482-A1 SOLVENT-FREE ENYNE METATHESIS POLYMERIZATION CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-02-06 WO disclosed
WO-2013040519-A2 IMPROVED ELECTROLYTIC CELL COVERS COMPRISING A RESIN COMPOSITION POLYMERIZED WITH A GROUP 8 OLEFIN METATHESIS CATALYST MATERIA, INC. (US) 2013-03-21 WO disclosed
US-8389752-B2 Preparation of alicyclic diepoxides Peomerus LLC (US) 2013-03-05 US disclosed
EP-2350062-A1 PREPARATION OF ALICYCLIC DIEPOXIDES Sumitomo Bakelite Company Limited (JP) 2011-08-03 EP disclosed
US-20100094030-A1 Preparation Of Alicyclic Diepoxides PROMERUS LLC (US) 2010-04-15 US disclosed
WO-2010042939-A1 PREPARATION OF ALICYCLIC DIEPOXIDES PROMERUS LLC (US) 2010-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100094030-A1 Preparation Of Alicyclic Diepoxides MVD, DLD, DHPS L3MBTL1 1114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.